Experimental treatments of endometriosis
This review summarizes novel experimental treatments for endometriosis, an estrogen-dependent disease, focusing on molecular targets to improve upon current therapies with significant side effects and limited efficacy for infertility.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (91)
- A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice via openalex
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane via openalex
- Antiangiogenesis therapy for endometriosis via openalex
- Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study via openalex
- An update on the pharmacological management of endometriosis via openalex
- Are aromatase inhibitors effective in endometriosis treatment? via openalex
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
- A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis via openalex
- Atorvastatin causes regression of endometriotic implants in a rat model via openalex
- Comparison of the effects of raloxifene and anastrozole on experimental endometriosis via openalex
- Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis via openalex
- Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis via openalex
- Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model via openalex
- Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis via openalex
- Effects of the novel orally active antiestrogen TZE-5323 on experimental endometriosis via openalex
- Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial via openalex
- Emerging drugs in endometriosis via openalex
- Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator via openalex
- Endometriosis via openalex
- Endometriosis and angiogenesis via openalex
- Endometriosis in the male via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue via openalex
- Hormone therapy for endometriosis and surgical menopause via openalex
- Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy via openalex
- Immunohistochemical analysis of the role of angiogenic status in the vasculature of peritoneal endometriosis via openalex
- Inflammatory status influences aromatase and steroid receptor expression in endometriosis via openalex
- Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques via openalex
- Involvement of estrogen receptor-related receptors in human ovarian endometriosis via openalex
- Lipoxin A4 inhibits the development of endometriosis in mice: the role of anti-inflammation and anti-angiogenesis via openalex
- Medical treatment of endometriosis via openalex
- Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells via openalex
- New medical treatments for endometriosis via openalex
- New trends for the medical treatment of endometriosis via openalex
- Novel therapies targeting endometriosis via openalex
- Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis via openalex
- Ovulation suppression for endometriosis via openalex
- Pentoxifylline for endometriosis via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis via openalex
- Regression of endometrial explants in a rat model of endometriosis treated with melatonin via openalex
- Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial via openalex
- Selective estrogen-receptor modulators and aromatase inhibitors: promising new medical therapies for endometriosis? via openalex
- Simvastatin protects against the development of endometriosis in a nude mouse model via openalex
- Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor via openalex
- Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients via openalex
- Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor via openalex
- Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix via openalex
- The effects of letrozole and melatonin on surgically induced endometriosis in a rat model: a preliminary study via openalex
- The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model via openalex
- The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex
- The emerging use of aromatase inhibitors for endometriosis treatment via openalex
- The epidemiology of endometriosis via openalex
- The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis via openalex
- Treatment of severe postmenopausal endometriosis with an aromatase inhibitor via openalex
- Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman via openalex
- Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model via openalex
- Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum via openalex
- W1993692236 via openalex
- W2003598961 via openalex
- W2066119115 via openalex
- W2066250307 via openalex
- W2066865081 via openalex
- W2067201007 via openalex
- W2070878775 via openalex
- W2078741915 via openalex
- W2079224311 via openalex
- W2082368668 via openalex
- W2084506573 via openalex
- W2085759082 via openalex
- W2089803739 via openalex
- W2096980318 via openalex
- W2099423538 via openalex
- W2015065898 via openalex
- W1985959551 via openalex
- W2126728673 via openalex
- W1969169755 via openalex
- W2132577372 via openalex
- W1965172511 via openalex
- W2139304464 via openalex
- W2140246703 via openalex
- W2145213731 via openalex
- W2154377312 via openalex
- W2156928884 via openalex
- W2159803441 via openalex
- W2160433381 via openalex
- W2170519509 via openalex
- W2587790761 via openalex
- W4211081176 via openalex
- W69917799 via openalex
Cited by (7)
- The Role of Dietary Supplements in the Management of Endometriosis-Related Symptoms: Current Evidence Based on a Systematic Review of Randomized Controlled Trials 2026
- Baicalein Relieves Ferroptosis-Mediated Phagocytosis Inhibition of Macrophages in Ovarian Endometriosis 2022
- Discerning Endometriosis as a Multifaceted Entity: A Comprehensive Review 2020
- Increasing Trends in Deep Infiltrating Endometriosis (DIE) with Bilateral Endometrioma from Adolescence till Menopause 2020
- Endometriosis with infertility: A comprehensive review on the role of immune deregulation and immunomodulation therapy 2020
- Increasing trends in Deep Infiltrating Endometriosis (DIE) with Bilateral Endometrioma from Adolescence till Menopause: Case Series 2019
- Roles of cell migration and invasion mediated by Twist in endometriosis 2019
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:16:08.491429+00:00